IMGN853-0401

First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMGN853 in Adults With Ovarian Cancer and Other FOLR1-Positive Solid Tumors


Fox Chase Cancer Center - Philadelphia
7604 Central Avenue Lower Level
Friends Hall Physicians Building
Philadelphia, PA 19111
215-728-4790

Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute
450 Brookline Ave., #SW-350
Boston, MA 02215

Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
617-643-2208

Princess Margaret Hospital
610 University Avenue
Toronto, ON M5G 2M9
416 946-4501

Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
410 West Tenth Avenue
Columbus, OH 43210
614-366-3802

Barbara Ann Karmanos Cancer Institute
3990 John R
Detroit, MI 48201
313-576-8753

Sarah Cannon Research Institute
250 25th Avenue North, Suite 110
Nashville, TN 37203
615-329-7432

University of Kansas Medical Center Research Institute
Fairway, KS 66205
913-945-7552

Stephenson Cancer Center at the University of Oklahoma
1200 Children's Ave. Suite 10000
Oklahoma City, OK 73104

University of Texas Health Science Center at San Antonio
7703 Floyd Curl Drive
San Antonio, TX 78229
210-450-3800